The intestinal anti-inflammatory activity of several doses of silymarin was
tested in the acute stage of the trinitrobenzenesulfonic acid (TNBS) model
of rat colitis. The results obtained show that oral pre-treatment with 50
mg/kg of silymarin significantly attenuated macroscopic colonic damage as w
ell as reduced colonic myeloperoxidase activity compared to nontreated coli
tic animals. The beneficial effect was accompanied by an improvement in the
colonic oxidative status, which was altered in colonic inflammation, by pr
eventing glutathione depletion and reducing malonyldialdehyde production. T
his suggests that the well known antioxidant properties of silymarin can pa
rticipate in its intestinal anti-inflammatory activity. In addition, a pres
ervation in the colonic absorptive function was also observed, and this eff
ect can also account for the colonic protective effect observed in this mod
el of acute colitis.